Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 5 H2 Revenue Recognition · US Site Cost Control · 2026 Profitability Defense / 2026-01-07 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Defense Export Expansion · GR Turnaround · 2026E Upward / 2026-02-19 Research
  • [Research] Alteogen (196170) – Hana Securities | New ALT-B4 Deal Signed · Qlex Prescription Surge · SC Conversion Acceleration / 2026-08-06 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Expanding Order Opportunities · 1Q26 Earnings Beat · Global Air Defense Growth / 2026-05-08 Research
  • [Research] Celltrion (068270) – Yuanta Securities | New Product Mix Expansion · Pipeline Addition · Earnings Growth / 2026-07-28 Research
  • [IR] Samsung Electronics (005930) – Q3 2025 Earnings Presentation / 2025-10-30 IR Room
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Contract Pricing · LTA · DRAM Supply Shortage / 2026-04-09 Research

[Research] Samsung SDI (006400) – IBK Securities | ESS Shipment Expansion · AMPC Benefits · Profit Turnaround / 2026-07-31

Posted on July 31, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : IBK Securities

Analyst : Hyun-wook Lee

Investment Rating : BUY (Maintained)

Target Price : KRW 800,000 (Maintained)

Core Momentum : Entering a fundamental earnings recovery phase following a turnaround to operating profit after seven quarters, driven by North American ESS capacity expansion and AMPC recognition.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: BUY (Maintained), Target Price KRW 800,000 (Maintained)
  • Market Data (As of 2026-07-30): Close KRW 358,500, Market Cap KRW 29.14 Trillion, Shares Outstanding 82,203 Thousand
  • Key Financial Forecasts (2025 → 2026F → 2027F):
    • Revenue: KRW 13.27 Trillion → KRW 15.56 Trillion → KRW 19.24 Trillion
    • Operating Profit: KRW -1.72 Trillion → KRW 352.0 Billion (Turnaround) → KRW 1.76 Trillion
    • Net Profit (Controlling): KRW -649.0 Billion → KRW 1.04 Trillion (Turnaround) → KRW 1.95 Trillion
    • EPS: KRW -8,325 → KRW 12,680 → KRW 23,685
    • Operating Margin (OPM): -13.0% → 2.3% → 9.1%
    • ROE: -3.2% → 4.7% → 8.3%
    • PER / PBR: -32.4x / 1.0x → 28.3x / 1.3x → 15.1x / 1.2x
    • EV/EBITDA: 87.3x → 16.3x → 9.5x

🚀 2. [Market Opportunities & Business Outlook]

  • 2Q26 Earnings Review: Revenue reached KRW 3.77 Trillion (QoQ +5.4%) and Operating Profit stood at KRW 204.0 Billion (Turnaround QoQ, OPM 5.4%), significantly exceeding consensus estimates (Revenue KRW 3.6 Trillion, Operating Profit KRW -27.0 Billion). Even excluding a one-off tariff refund of approximately KRW 200.0 Billion, the company achieved underlying profitability, supported by increased European exports of SPE EV batteries (AMPC of KRW 107.7 Billion recognized) and narrowed losses in small batteries.
  • Segment Outlook:
    • ESS Segment: Total ESS manufacturing capacity is projected to reach 42GWh by end-2026 (Ulsan 10GWh, China 3GWh, North America 29GWh). Out of the 36GWh eligible for AMPC, 2026 AMPC recognition is estimated at 10.4GWh (KRW 491.4 Billion). Shipments are expected to grow sequentially driven by domestic utility-scale projects in 3Q26 and the initial rollout of LFP ESS products in 4Q26.
    • EV Segment: While shipments of P6 high-nickel products for European Hyundai/Kia models (Ioniq9, EV2) began ramping up in 2Q26, lower shipments to SPE EV are expected to lead to modest softness in 2H26 EV shipments compared to 2Q26 levels.

📝 Editor’s Comment (Perspective)

The analyst views Samsung SDI not merely as an EV-dependent battery supplier navigating demand headwinds, but as an energy storage player entering an operational turnaround underpinned by North American ESS capacity expansion and AMPC accruals. This perspective places primary importance on passing the sector-wide earnings trough through ESS-led structural profit contribution, rather than relying strictly on an immediate EV demand recovery.

To evaluate the ongoing validity of this investment thesis, key monitoring factors include the commercial scaling and volume shipments of LFP ESS starting in 4Q26, the realization of the projected 10.4GWh in annual AMPC benefits, and the sustainability of core operating profitability independent of one-time tariff reimbursements. These operational milestones can be verified through upcoming quarterly earnings releases, official company IR disclosures, and periodic statutory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, EV & Battery

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Kyobo | HBM4 · Product Mix · LTA / 2026-07-30
Next Post: [Research] Samsung SDI (006400) – Shinhan Securities | ESS & BBU Growth · Profit Turnaround · Core Earnings Sustainability / 2026-07-31

Related Posts

  • [Research] Samsung Biologics (207940) – Shinhan Securities | Wage Negotiation Factors · Rockville Ramp-up · Plant 6 Catalyst / 2026-07-01 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Clinical Data · Pipeline Progress · Tech Transfer / 2026-05-21 Research
  • [Research] SK hynix (000660 / SKHY) – SK Securities | LTA · Capex Discipline · Cycle Stability / 2026-01-28 Research
  • [Research] Samsung SDI (006400/KS) – SK Securities | Prominent Base Effects · Conservative CapEx Management · Compelling Valuation / 2026-02-03 Research
  • [Research] LIG D&A (079550) – Eugene Investment & Securities | Non-Cheongung Potential · High-margin Legacy Defense · Earnings Surprise / 2026-05-08 Research
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | LTA · Premium Product Mix · Blended ASP / 2026-07-14 Research
  • [Research] Samsung SDI (006400) – Kiwoom Securities | Quarterly Turnaround · ESS LFP Ramp-up · Europe EV Market Share / 2026-07-31 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-term Exclusive Contracts · 2029 Target EPS · Structural ASP Hikes / 2026-06-01 Research
  • [Research] LigaChem Biosciences (141080) – Kyobo Securities | Pipeline Clinical Progress · IND Filings · Tech Transfer / 2026-04-01 Research
  • [IR] SK hynix (000660 / SKHY) – Q3 2024 Earnings Presentation / 2024-10-24 IR Room
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Contract Pricing · LTA · DRAM Supply Shortage / 2026-04-09 Research
  • [Research] Alteogen (196170) – Shinhan Securities | 2 Out-Licensing Deals in Q1 · Biogen Deal Analysis · Major Catalysts Ahead from April / 2026-03-27 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | US ESS Surges · 4Q LFP Ramp-Up · Cyclical Bottom Passed / 2026-02-03 Research
  • [Research] LIG D&A (079550) – iM Securities | Premier Air Defense Scarcity · Target Price Upgrade · Global Inquiries / 2026-05-08 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme